Genetic testing can identify individuals who are at higher risk for toxicity due to their genetic makeup. For example, testing for HLA-B*57:01 can identify those at risk for severe hypersensitivity reactions to the drug abacavir. Such information can guide clinicians in choosing safer alternatives or adjusting dosages.
